Selecting Core Outcomes for Randomised Effectiveness trials In Type 2 Diabetes (SCORE-IT): study protocol for the development of a core outcome set.

ABSTRACT:

Background

Type 2 diabetes is characterised by abnormal glucose metabolism, and treatment is aimed at normalising glycaemia. Outcomes measured in clinical trials should be meaningful to patients, health care professionals and researchers, yet there is heterogeneity in the outcomes used across trials of glucose-lowering interventions. This inconsistency affects the ability to compare findings and may mean that the results have little importance to health care professionals and the patients for whom they care. The SCORE-IT study aims to develop a core outcome set (COS) for use in all trials of glucose-lowering interventions for people with type 2 diabetes.

Methods/design

This study will involve three key stages in the development of a COS: (1) A list of outcomes will be identi

SUBMITTER: Harman NL 

PROVIDER: S-EPMC6081933 | biostudies-literature | 2018 Aug

REPOSITORIES: biostudies-literature